|
Market Closed -
Other stock markets
|
After hours 20:59:59 | |||
| 697.00 EUR | +3.75% |
|
695.90 | -0.16% |
| 04:21pm | European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading | MT |
| 02:35pm | Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday | MT |
| Capitalization | 41.11B 47.85B 38.34B 35.63B 66.47B 4,321B 71.68B 441B 173B 2,065B 179B 176B 7,616B | P/E ratio 2025 * |
44.7x | P/E ratio 2026 * | 27.9x |
|---|---|---|---|---|---|
| Enterprise value | 38.09B 44.33B 35.52B 33B 61.58B 4,003B 66.4B 408B 160B 1,913B 166B 163B 7,055B | EV / Sales 2025 * |
10.6x | EV / Sales 2026 * | 7.37x |
| Free-Float |
99.23% | Yield 2025 * |
0.02% | Yield 2026 * | 0.04% |
Last Transcript: argenx SE
| 1 day | +3.75% | ||
| 1 week | +1.96% | ||
| Current month | -2.76% | ||
| 1 month | -7.46% | ||
| 3 months | +1.69% | ||
| 6 months | +45.06% | ||
| Current year | -2.76% |
| 1 week | 660.4 | 711.6 | |
| 1 month | 660.4 | 745.2 | |
| Current year | 660.4 | 728 | |
| 1 year | 456.6 | 810 | |
| 3 years | 271 | 810 | |
| 5 years | 201.4 | 810 | |
| 10 years | 9.23 | 810 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 14/07/2008 | |
Karl Gubitz
DFI | Director of Finance/CFO | 56 | 31/05/2021 |
Filip Borgions
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 30/06/2014 | |
| Chairman | 68 | 14/10/2008 | |
Joseph deBethizy
BRD | Director/Board Member | 76 | 12/05/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.75% | +1.96% | +8.23% | +89.61% | 48.01B | ||
| +6.00% | +10.61% | +96.03% | +15.05% | 41.97B | ||
| -2.38% | -6.48% | +137.52% | +741.75% | 35.77B | ||
| +4.90% | +9.28% | -5.76% | -26.10% | 25.64B | ||
| -0.74% | +6.77% | +33.50% | -21.62% | 20.81B | ||
| +5.85% | +18.68% | +131.28% | -41.71% | 19.92B | ||
| -1.35% | -9.91% | -7.51% | +250.21% | 13.14B | ||
| -4.36% | +2.99% | +114.78% | +162.46% | 14.9B | ||
| -1.68% | +11.30% | +190.69% | - | 14.63B | ||
| +0.05% | +0.92% | +24.87% | +168.29% | 11.86B | ||
| Average | +0.95% | +4.84% | +72.36% | +148.66% | 24.67B | |
| Weighted average by Cap. | +1.81% | +3.68% | +69.75% | +160.41% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.6B 4.18B 3.35B 3.12B 5.81B 378B 6.27B 38.55B 15.15B 181B 15.69B 15.37B 666B | 4.97B 5.78B 4.63B 4.3B 8.03B 522B 8.66B 53.24B 20.92B 249B 21.67B 21.23B 920B |
| Net income | 984M 1.15B 918M 853M 1.59B 103B 1.72B 10.55B 4.15B 49.44B 4.3B 4.21B 182B | 1.74B 2.02B 1.62B 1.5B 2.81B 182B 3.03B 18.61B 7.31B 87.21B 7.58B 7.42B 322B |
| Net Debt | -3.03B -3.52B -2.82B -2.62B -4.89B -318B -5.27B -32.43B -12.74B -152B -13.2B -12.93B -560B | -4.53B -5.27B -4.23B -3.93B -7.33B -476B -7.9B -48.57B -19.09B -228B -19.77B -19.37B -839B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/01/26 | 697.00 € | +3.75% | 81,786 |
| 12/01/26 | 671.80 € | -3.14% | 97,384 |
| 09/01/26 | 693.60 € | -0.49% | 100,368 |
| 08/01/26 | 697.00 € | -0.88% | 86,482 |
| 07/01/26 | 703.20 € | +2.51% | 108,872 |
Real-time Euronext Bruxelles, January 13, 2026 at 04:55 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ARGX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















